Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
AYMAN KOTEISH
Listed Specialty: Transplant Hepatology
2415 N ORANGE AVE, SUITE 700, ORLANDO, FL, 32804-5505
Is this you? Do you believe the data contains errors? Click here for information →
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
AYMAN KOTEISH,
Yearly Payment Breakdown:
2018 Payments At a Glance
67
payments
$67,785
payment total
6
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
| Category | Payments | Payment Value |
|---|---|---|
Promotional Speaking/Other |
21 | $57,800 |
Travel and Lodging |
22 | $7,221 |
Food and Beverage |
23 | $1,864 |
Consulting |
1 | $900 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
| Product Name | Product Type | Payments† |
|---|---|---|
MAVYRET |
drug |
$20,823 |
EPCLUSA |
drug |
$19,950 |
VEMLIDY |
drug |
$14,877 |
DOPTELET |
drug |
$10,964 |
STIVARGA |
drug |
$900 |
Payments with no listed product |
N/A |
$146 |
KEYTRUDA |
drug |
$125 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
Payment Details in 2018
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| Oct 26, 2018 | $4,550 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| Nov 6, 2018 | $4,550 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| Feb 19, 2018 | $3,500 | VEMLIDY | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Dec 3, 2018 | $3,500 | VEMLIDY | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Aug 29, 2018 | $3,250 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| Sep 24, 2018 | $3,250 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| Aug 27, 2018 | $3,250 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| Aug 17, 2018 | $3,000 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| May 3, 2018 | $3,000 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Jan 15, 2018 | $3,000 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Sep 15, 2018 | $3,000 | VEMLIDY | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| May 21, 2018 | $3,000 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Dec 5, 2018 | $2,750 | DOPTELET | Promotional Speaking/Other | DOVA PHARMACEUTICALS | |
| Dec 18, 2018 | $2,750 | DOPTELET | Promotional Speaking/Other | DOVA PHARMACEUTICALS | |
| Nov 28, 2018 | $2,750 | DOPTELET | Promotional Speaking/Other | DOVA PHARMACEUTICALS | |
| Mar 19, 2018 | $2,500 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Aug 28, 2018 | $2,500 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Feb 19, 2018 | $1,750 | VEMLIDY | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Dec 5, 2018 | $1,250 | DOPTELET | Promotional Speaking/Other | DOVA PHARMACEUTICALS | |
| Oct 17, 2018 | $963 | MAVYRET | Travel and Lodging | ABBVIE, INC. | |
| Sep 28, 2018 | $900 | STIVARGA | Consulting | BAYER HEALTHCARE PHARMACEUTICALS INC. | |
| Jan 11, 2018 | $711 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Nov 28, 2018 | $672 | DOPTELET | Travel and Lodging | DOVA PHARMACEUTICALS | |
| Nov 1, 2018 | $501 | MAVYRET | Travel and Lodging | ABBVIE, INC. | |
| Nov 29, 2018 | $497 | VEMLIDY | Travel and Lodging | GILEAD SCIENCES INC | |
| Dec 18, 2018 | $480 | DOPTELET | Travel and Lodging | DOVA PHARMACEUTICALS | |
| Feb 15, 2018 | $396 | VEMLIDY | Travel and Lodging | GILEAD SCIENCES INC | |
| May 5, 2018 | $381 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Mar 9, 2018 | $350 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Oct 12, 2018 | $350 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Sep 15, 2018 | $347 | VEMLIDY | Travel and Lodging | GILEAD SCIENCES INC | |
| Sep 15, 2018 | $319 | VEMLIDY | Travel and Lodging | GILEAD SCIENCES INC | |
| Nov 29, 2018 | $308 | VEMLIDY | Travel and Lodging | GILEAD SCIENCES INC | |
| Feb 15, 2018 | $304 | VEMLIDY | Travel and Lodging | GILEAD SCIENCES INC | |
| Feb 15, 2018 | $292 | VEMLIDY | Travel and Lodging | GILEAD SCIENCES INC | |
| May 5, 2018 | $276 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| May 5, 2018 | $250 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Sep 15, 2018 | $230 | VEMLIDY | Travel and Lodging | GILEAD SCIENCES INC | |
| Nov 28, 2018 | $127 | DOPTELET | Food and Beverage | DOVA PHARMACEUTICALS | |
| Dec 5, 2018 | $125 | DOPTELET | Food and Beverage | DOVA PHARMACEUTICALS | |
| Oct 24, 2018 | $125 | KEYTRUDA | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Nov 29, 2018 | $122 | VEMLIDY | Food and Beverage | GILEAD SCIENCES INC | |
| May 5, 2018 | $120 | EPCLUSA | Food and Beverage | GILEAD SCIENCES INC | |
| Sep 15, 2018 | $120 | VEMLIDY | Food and Beverage | GILEAD SCIENCES INC | |
| Aug 22, 2018 | $116 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Jul 12, 2018 | $113 | No Listed Product | Food and Beverage | MELINTA THERAPEUTICS, INC. | |
| Aug 21, 2018 | $111 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Sep 19, 2018 | $110 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Jan 11, 2018 | $103 | EPCLUSA | Food and Beverage | GILEAD SCIENCES INC | |
| Aug 15, 2018 | $101 | EPCLUSA | Food and Beverage | GILEAD SCIENCES INC | |
| Oct 17, 2018 | $94 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| May 22, 2018 | $87 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Aug 24, 2018 | $74 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Dec 18, 2018 | $60 | DOPTELET | Food and Beverage | DOVA PHARMACEUTICALS | |
| Sep 15, 2018 | $50 | VEMLIDY | Food and Beverage | GILEAD SCIENCES INC | |
| Sep 15, 2018 | $50 | VEMLIDY | Food and Beverage | GILEAD SCIENCES INC | |
| May 5, 2018 | $49 | EPCLUSA | Food and Beverage | GILEAD SCIENCES INC | |
| Mar 5, 2018 | $47 | VEMLIDY | Food and Beverage | GILEAD SCIENCES INC | |
| May 5, 2018 | $44 | EPCLUSA | Food and Beverage | GILEAD SCIENCES INC | |
| Mar 5, 2018 | $44 | VEMLIDY | Travel and Lodging | GILEAD SCIENCES INC | |
| Aug 30, 2018 | $35 | MAVYRET | Travel and Lodging | ABBVIE, INC. | |
| Jun 11, 2018 | $29 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| Jun 11, 2018 | $24 | EPCLUSA | Travel and Lodging | GILEAD SCIENCES INC | |
| May 24, 2018 | $23 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Nov 11, 2018 | $19 | MAVYRET | Food and Beverage | ABBVIE, INC. | |
| Jan 10, 2018 | $17 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC | |
| Dec 12, 2018 | $17 | No Listed Product | Food and Beverage | GILEAD SCIENCES INC |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.